Benzinga's Top Downgrades

By: via Benzinga
Analysts at Nomura downgraded Pharmacyclics Inc. (NASDAQ: PCYC) from Buy to Neutral. The price target for Pharmacyclics has been raised ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.